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Proteins Transduced by Cation Channels
J. Golledge*, M. Gosling, R. J. Turner, N. J. Standfield and J. T. Powell
Imperial College School of Medicine at Charing Cross Hospital, Department of Vascular Surgery,
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Objectives: expression of leukocyte adhesins and proteins controlling thrombosis is likely to be an important determinant
of graft patency early following vein bypass. We have previously demonstrated rapid increase in endothelial ICAM-1 and
nitric oxide synthase (eNOS) concentrations in human saphenous vein exposed to arterial flow. The aim of this study
was to investigate whether ion-channel-blocking drugs could alter these flow-induced changes.
Methods: human saphenous vein segments, freshly excised from patients, were placed in a validated in vitro circuit
using flow conditions shown to simulate arterial or venous circulations for 90 min, in the presence or absence of ion-
channel blockers. The concentrations of ICAM-1, VCAM-1, eNOS and tissue factor (TF) were assessed by quantitative
immunohistochemistry in vein exposed to flow and compared with that in freshly excised vein from the same patient.
The endothelial protein concentration was calculated as the mean area of staining as percentage of that for the control
protein CD31, using computer-aided image analysis.
Results: after arterial flow conditions the area ratio of ICAM-1 increased from 21.4–1.4 to 44.6–2.0%, of eNOS
increased from 50.0–5.6 to 70.1–5.0%, of VCAM-1 decreased from 16.6–3.4 to 3.6–1.0%, whereas TF staining area
ratio was unchanged. Inclusion of the non-selective K+ channel blocker, tetraethylammonium, in the arterial perfusion
solution abolished all these arterial flow-induced changes. Inclusion of the K+ATP channel blocker, glibenclamide, selectively
abolished the arterial flow-induced changes in ICAM-1 and VCAM-1. Inclusion of the calcium channel blocker, nifedipine,
abolished the arterial flow-induced changes in eNOS and VCAM-1 but increased the TF staining area ratio from 3.0–0.4
to 8.5–0.7%, p=0.01. Inclusion of the stretch-activated cation-channel blocker, gadolinium, enhanced the arterial flow-
induced increase in eNOS, but prevented the arterial flow-induced increase in ICAM-1.
Conclusions: perfusion of veins under arterial flow conditions with gadolinium was associated with low endothelial
concentrations of ICAM-1, VCAM-1 and TF, but high levels of eNOS. Such a concentration of endothelial proteins may
be advantageous in newly implanted vein grafts. In contrast, nifedipine could have adverse effects by promoting increase
in TF concentration.
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Introduction (ICAM-1), vascular cell adhesion molecule-1 (VCAM-
1) and endothelial nitric oxide synthase (eNOS).4–6 The
Aortocoronary or infrainguinal vein bypass requires mechanisms by which shear stress and stretch are
that saphenous vein be transferred from the venous transduced into changes in protein expression are
to the arterial circulation. The response of the vein to becoming clear and include realignment of structural
this change in environment appears to be one of the proteins and cytoskeleton,7 activation of ion chan-
factors leading to graft failure.1–3 Following bypass the nels,8 and signalling cascades dependent on protein
vein is exposed to a variety of new forces, including phosphorylation.9
increased shear stress, circumferential and radial de- The opening of ion channels is the earliest reported
formation, both in a static and pulsatile fashion.2,3 response to increased shear stress, occurring in milli-
These forces have been shown to induce complex seconds and therefore perhaps one of the most im-
changes on the endothelium, including important al- portant mechanisms of transducing early responses
terations in the molecules controlling leukocyte ad- to changes in haemodynamic forces.8 For example,
hesion, such as intercellular adhesion molecule-1 blockade of potassium channels with tetra-
ethylammonium prevents the release of nitric oxide
* Please address all correspondence to: J. Golledge, Department of from the endothelium stimulated by shear stress.10Vascular Surgery, Charing Cross Hospital, Fulham Palace Road,
London W6 8RF, U.K. Moreover, ion-channel-blocking drugs, e.g. nifedipine
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and glibenclamide, are commonly prescribed in remainder divided for histology or immuno-
histochemistry.patients undergoing vein bypass, and therefore could
potentially alter the early response of the vein to
Immunohistochemistryarterial flow. We have previously described rapid
Vein specimens for immunohistological analysis werechanges in saphenous vein endothelial proteins in
immersed in Zamboni’s fixative overnight at 4 °C, thenresponse to circumferential deformation and shear
washed thoroughly in PBS-sucrose over 3 to 7 days.stress in an in vitro model of vein bypass.5,11 In this
Fixed specimens were mounted on cork and frozenstudy we investigate the role of potassium, calcium
in isopentane suspended in liquid nitrogen. Cryostatand stretch-activated cation (SAC) channels in the
sections (8–10 lM) were prepared on slides coatedchanges of saphenous vein endothelium proteins in-
with poly-L-lysine and serial sections stained by theduced by arterial flow.
ABC immunoperoxide method,5,11 using antibodies to
CD31 (monoclonal, R & D Systems, U.K., 1 in 1000),
eNOS (monoclonal, kind gift from Dr J. Pollock, Med-
ical College of Georgia, Augusta, GA, U.S.A., 1 inMethods
1000), ICAM-1 (monoclonal, Serotec, Oxford, U.K.),
VCAM-1 (monoclonal, kind gift of Professor DorianVein samples
Haskard, Department of Medicine, Imperial CollegeSaphenous vein was harvested from patients under-
School of Medicine, London), and tissue factor (poly-going aortocoronary or infrainguinal bypass, am-
clonal, kind gift from Professor Y. Nemerson, Mountputation or high ligation of saphenous vein for
Sinai School of Medicine, New York, NY, U.S.A.).correction of varicose veins, and immediately brought
to the laboratory in ice-cold Krebs solution. Vein func-
Quantitation of immunostainingtion was assessed by organ chamber pharmacology.11
Five to 10 sections from areas along each specimenDiseased vein, which did not respond to 10 lM phenyl-
were assessed for immunostaining area of relevantephrine with a contraction of >2 g and then relax to
protein using computer-assisted image analysis (Sym-A23187 (1 lM), was discarded. Samples from smokers
phony image analysis system, Seescan). To minimiseand patients with diabetes were excluded. The local
inconsistencies, samples to be quantified were pre-Ethical Committee approved these procedures.
pared and stained at the same time. Digitised images
representing the whole transverse section of the vesselThe flow circuit
were segmented by interactive thresholding to sep-The development and validation of the flow circuit
arate endothelial immunostaining from background.has been previously described in detail.5,11 Saphenous
The endothelial staining was highlighted using avein segments were mounted in a retaining jig, after
cursor, and background luminal and medial stainingremoval of a control section of vein for histology and
excluded. The area of staining was computed fromimmunohistochemistry. The jig was then placed in a
serial sections for paired flow and control freshlybath of oxygenated Krebs’ solution (NaCl 118.4, KCl
excised samples using identical intensity settings.4.7, KH2PO4 1.2, MgSO4·7H2O 1.2, glucose 11.1,
NaHCO3 24.9, CaCl2 2.5 mMol/L) warmed to 36.5 °C Western blotting
(oxygen content 20 ml/l) from a 1-L reservoir. The The method for Western blotting has been previously
perfusion pressure, flow rate and internal vein dia- described in detail.5 In brief, endothelial cell lysates
meter were monitored.5,11 Vein segments were exposed from vein samples underwent SDS-PAGE (Phast Sys-
either to pulsatile flow (80 cpm) at a mean pressure of tems 8–25% gradient acrylamide gel, Amersham, Little
100 mmHg (arterial flow) for 90 minutes (flow rate Chalfont, U.K.). The proteins were transferred to
200–225 ml/min, average shear stress 0.26–0.09 N/ Hybond-PVDF membrane and incubated with ap-
m2) or to non-pulsatile flow at 20 mmHg (venous flow) propriate antibodies. Processing was completed for
for 90 minutes (flow rate 10–20 ml/min, average shear enhanced chemiluminescence detection. The staining
stress 0.021–0.011 N/m2).5,11 In separate experiments intensity of specific bands was quantified by den-
3 mM tetraethylammonium chloride (TEA) to non- sitometric scanning, and changes were standardised
selectively block K+ channels, 5 lM glibenclamide to with respect to control-protein von Willebrand factor
block K+ATP channels, 10 lM gadolinium chloride (vWF).5
(Gd3+) to block stretch-activated channels or 20 lM
nifedipine to block Ca2+ channels were added to the Analysis of results
Immunostaining was principally used to assess proteinvein perfusate. At the end of the flow experiment
the vein was removed, the ends discarded and the changes, with some experiments also repeated for
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Western blotting. To allow for the minor endothelial 2); a finding confirmed on Western blotting for gado-
linium (Table 3). However, when TEA (3 mM) or ni-loss observed by CD31 immunostaining and the di-
latation that occurs in response to arterial flow, the fedipine (20 lM) were added to the vein perfusate
there was no increase in the eNOS/CD31 staining areastaining areas for ICAM-1, eNOS and VCAM-1 were
expressed as percentage of CD31 staining.5,11 CD31 after 90 minutes of arterial flow (Table 2). By Western
blotting the eNOS/vWF staining density similarly didstaining has previously been shown not to alter sig-
nificantly in response to arterial flow for 90 minutes.11 not increase in the presence of TEA, however, the
eNOS/vWF staining density increased 4-fold whenImmunostaining areas (mean–standard error) were
compared for paired samples using Student’s paired vein samples were exposed to arterial flow in the
presence of nifedipine (Table 3).t-test and for unpaired samples using unpaired Stu-
dent’s t-test.
Results The effect of cation-channel blockade on flow-induced
decrease in VCAM-1
The effect of cation-channel blockade on flow-induced
After vein had been exposed to arterial flow conditionsincrease in ICAM-1
for 90 minutes the ratio of VCAM-1/CD31 staining
area decreased approximately 5-fold as compared withWe have previously reported the 2-fold increase in
ICAM-1/CD31 staining area following 90 minutes of paired freshly excised vein or vein exposed to venous
flow (Table 1, Fig. 1). After inclusion of Gd3+ (10 lM)arterial flow in comparison to freshly excised vein or
samples exposed to venous flow (Table 1).5,11 A similar in the vein perfusate, a similar reduction in VCAM-
1/CD31 staining-area ratio was observed after arterial2-fold increase in ICAM-1/vWF staining density was
demonstrated on Western blotting.5 When the calcium flow conditions for 90 minutes (Table 2). However,
when TEA (3 mM), glibenclamide (5 lM), or nifedipinechannel-blocker nifedipine (20 lM) was included in
the vein perfusate during 90 minutes of simulated (20 lM) were included in the vein perfusate there was
no reduction in the VCAM-1/CD31 staining ratio afterarterial flow a similar 2-fold increase in ICAM-1 con-
centration was observed in comparison to freshly ex- 90 minutes of arterial flow (Table 2).
cised vein (Table 2). However, when the non-selective
K+ channel-blocker tetraethylammonium chloride
(3 mM), the K+ATP channel-blocker glibenclamide
(5 lM) or the stretch-activated cation-channel-blocker
gadolinium (10 lM) were added to the vein perfusate The effect of arterial flow and cation-channel blockade on
of samples exposed to arterial flow the increase in saphenous vein endothelial tissue factor
ICAM-1/CD31 staining area was not observed (Tables
1 and 2). There was similarly no increase in ICAM-1/ Tissue factor is the most important stimulant of the
vWF staining density when vein samples were exposed clotting cascade. In freshly excised saphenous vein
to arterial flow in the presence of TEA (Table 3). there was very little endothelial staining for TF. The
endothelial TF/CD31 staining-area ratio was un-
changed following 90 min of arterial flow compared
with paired freshly excised vein or vein exposed to
venous flow (Table 1). The inclusion of Gd3+ (10 lM),The effect of cation-channel blockade on flow-induced
increase in eNOS TEA (3 mM) or glibenclamide (5 lM) in the vein per-
fusate during 90 min of arterial flow did not alter
Following simulated arterial flow for 90 minutes the the endothelial TF/CD31 staining-area ratio (Table
2). However, when saphenous vein was exposed tostaining ratio eNOS/CD31 increased 1.5-fold as com-
pared to freshly excised vein. This change was con- arterial flow in the presence of nifedipine (20 lM) there
was a significant two-fold increase in the endothelialfirmed by a similar increase in Western blotting
staining density.5 When Gd3+ (10 lM) or glibenclamide TF/CD31 staining-area ratio (p<0.02) (Table 2). This
increase in tissue-factor staining when vein samples(5 lM) were included in the vein perfusate, a similar
increase in eNOS/CD31 staining-area ratio was ob- were exposed to arterial flow in the presence of ni-
fedipine was confirmed on Western blotting (Table 3).served in comparison with freshly excised vein (Table
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Table 1. Immunostaining area of endothelial proteins: effect of arterial flow.
Flow conditions n ICAM-1 VCAM-1 eNOS Tissue factor
Freshly excised vein 8 21.4–1.4 16.6–3.4 50.0–5.6 3.0–0.4
Venous flow (90 min) 8 20.0–2.0 15.0–2.5 44.0–6.0 3.0–0.5
Arterial flow (90 min) 8 44.6–2.0 3.6–1.0 70.1–5.0 3.0–4.0
Numbers are percentage of CD31 staining, mean–standard error of the mean.
As previously reported, endothelial staining ratio for ICAM-1 increased 2-fold after 90 minutes of arterial flow,
compared to freshly excised vein.5,11
As previously reported, endothelial staining ratio for VCAM-1 decreased 3-fold after 90 minutes of arterial
flow, compared to freshly excised vein.5
The endothelial staining ratio for eNOS increased 1.5-fold after 90 minutes of arterial flow, compared to freshly
excised vein.5
The endothelial tissue factor/CD31 staining area was unaffected by arterial flow for 90 minutes, compared to
freshly excised vein.
None of the staining areas were affected by venous flow.
Table 2. Immunostaining area of endothelial proteins: effect of blocking ion channels.
Arterial flow (90 min)
with different perfusates n ICAM-1 VCAM-1 eNOS Tissue factor
Krebs alone 8 44.6–2.0 3.6–1.0 70.1–5.0 3.0–0.4
Krebs & 10 lM gadolinium 5 21.2–2.4* 2.7–0.5 84.5–6.0 2.6–0.4
Krebs & 3 mM TEA 6 20.0–1.0* 17.5–2.0* 47.0–3.0* 2.9–0.2
Krebs & 5 lM glibenclamide 5 21.7–3.5* 21.0–5.5* 66.1–6.0 5.8–0.5
Krebs & 20 lM nifedipine 5 38.0–2.3 20.0–5.5* 56.0–3.1* 8.5–0.7†
Results are given as percentage of CD31 staining, mean–standard error of the mean. In this table all comparisons of
staining-ratio areas are with veins perfused with Krebs’ solution alone.
* The arterial flow-induced changes in ICAM-1, VCAM-1, and eNOS were abolished, p<0.04 (unpaired t-test).
† Tissue-factor staining was minimal except in vein exposed to arterial flow in the presence of nifedipine, when there
was a significant increase in staining (†p<0.02).
Table 3. Western blotting of endothelial proteins: effect of blocking ion channels.
Arterial flow (90 min)
with different perfusates n ICAM-1 eNOS Tissue factor
Krebs alone 8 0.45–0.04 1.5–0.01 0.21–0.08
Krebs & 10 lM gadolinium 5 nd 1.63–0.32 nd
Krebs & 3 mM TEA 6 0.23–0.04* 0.25–0.05* nd
Krebs & 20 lM nifedipine 5 0.46–0.12 1.35–0.16 0.35–0.1†
Results are given as ratio of vWF staining density,5 mean–standard error of the mean. In this table all
comparisons of staining-ratio areas are with veins perfused with Krebs’ solution alone.
* The arterial flow-induced changes in ICAM-1, and eNOS were abolished, p<0.04 (unpaired t-test).
† Tissue-factor staining was minimal except in vein exposed to arterial flow in the presence of nifedipine,
when there was a significant increase in staining (†p<0.05).
nd=not done.
Discussion of arterial flow there is a two-fold increase in ICAM-
1, a 1.5-fold increase in eNOS and a five-fold decrease
in VCAM-1, while there is no change in the scantIn this study we have extended our previous work5,11
regarding the early effects of arterial flow on sa- endothelial staining for tissue factor, in comparison to
freshly excised vein (Table 1). The molecular eventsphenous vein endothelial proteins. After only 90 min
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glibenclamide and the stretch-activated cation-channel
blocker gadolinium had more selective effects (Table
2).
Ideally we might have hoped to be able to identify
the particular ion channel important in signalling each
change in saphenous vein protein induced by arterial
flow. However, dissection of the role of individual ion
channels is hampered by a number of limitations.
Firstly, it is clear that most ion-channel-blocking drugs
have ancillary actions. For example calcium-channel
blockers (CCB) have been recently demonstrated to
have direct effects on transcriptional factors in-
dependent of their influence on calcium channels,12
and gadolinium in addition to blocking SAC channels
may also have effects on some calcium and potassium
channels.8 Secondly, while whole-tissue preparations
have the advantage of being nearer to the in vivo
situation, they allow for interaction between endo-
thelium and smooth-muscle cells, which may com-
plicate interpretation of experiments. In arterioles,
electronic coupling from smooth muscle to endo-
thelium has been reported.13 Thus, some of the actions
of the cation-channel blockers may be on the intimal
smooth-muscle cells, with secondary effects on the
endothelium. Finally, the action of one ion channel
may affect that of another; such that two channels
may interact to transduce a signal. For example, ac-
tivation of SAC channels will lead to an increase in
cytosolic calcium concentration, which has been shown
to induce opening of some K+ channels.8
Many patients undergoing coronary or infrainguinal
vein bypass are prescribed ion-channel-blocking
drugs, such as nifedipine or glibenclamide. For ex-
ample, in a study of patients undergoing coronary
revascularisation, 41% of patients were taking a CCB,
Fig. 1. Effect of arterial flow on staining for VCAM-1. Staining for although not all of these will have been di-
VCAM-1 was intermittent on freshly excised vein (b), and decreased
hydropyridines.14 Animal studies and clinical trialsfollowing arterial flow for 90 minutes (c). A negative control is
shown (a). suggest that dihydropyridines may have a role in
decreasing the rate of development of atherosclerotic
lesions, and therefore the prescribing of these agentsleading to alteration in expression of ICAM-1, VCAM-
is likely to increase.15 Results from this study suggest1, and eNOS appear complex. In an earlier study we
that nifedipine may have detrimental effects earlydemonstrated that in our model of vein bypass the
following vein bypass. In vein segments exposed toprincipal force stimulating early changes in ICAM-1
arterial flow in the presence of 20 lM nifedipine highand VCAM-1 expression is circumferential de-
endothelial concentrations of ICAM-1 and VCAM-1,formation, while shear stress is the important haemo-
but low concentrations of eNOS, were demonstrateddynamic force inducing early increase of eNOS.5 The
(Table 2). This concentration of endothelial proteins isresults of this study suggest that several different ion
likely to favour leukocyte adhesion and infiltration,channels participate in regulating the early responses
early following vein grafting, which may be an im-of saphenous vein to arterial flow. Addition of the
portant mechanism in subsequent graft stenosis.16–19non-selective K+ channel blocker TEA to the vein
Moreover, addition of nifedipine to the perfusate ofperfusate prevented all the early changes in saphenous
vein segments exposed to arterial flow was also as-vein endothelial proteins demonstrated in vein ex-
posed to arterial flow. In contrast the K+ATP blocker sociated with a significant increase in staining for the
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